CASTLE BIOSCIENCES, INC. Total Assets
CASTLE BIOSCIENCES, INC. (CSTL) had Total Assets of $561.18 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2026-07-30
- 2026-06-30: Assets $561.18M.
- 2026-03-31: Assets $547.80M.
- 2025-12-31: Assets $578.56M.
- 2025-09-30: Assets $562.79M.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2026-06-30 | $561.18M 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $547.80M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $578.56M 10-Q · filed 2026-07-30 | |
| 2025-09-30 | $562.79M 10-Q · filed 2025-11-03 | |
| 2025-06-30 | $544.73M 10-Q · filed 2025-08-04 | |
| 2025-03-31 | $501.71M 10-Q · filed 2025-05-05 | |
| 2024-12-31 | $531.24M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $514.57M 10-Q · filed 2024-11-04 | |
| 2024-06-30 | $487.31M 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $458.51M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $453.34M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $436.02M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $425.40M 10-Q · filed 2023-08-02 | |
| 2023-03-31 | $426.89M 10-Q · filed 2023-05-03 | |
| 2022-12-31 | $447.33M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $457.81M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $458.38M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $444.43M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $462.57M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $433.69M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $435.53M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $437.33M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $439.33M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $210.39M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $201.55M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $120.26M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $119.75M 10-K · filed 2021-03-11 | |
| 2019-09-30 | $113.20M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $33.35M 10-Q · filed 2019-09-03 | |
| 2018-12-31 | $22.41M 10-K · filed 2020-03-10 | $22.40M 10-Q · filed 2019-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |